Overview
- 8 FDA inspections are on record.
- 5 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-01-15.
At a glance
Inspections
8
Form 483s
5
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 9 Jan 2026 – 15 Jan 2026 | Human Drugs | 483 | View 483 → |
| 30 Jun 2025 – 2 Jul 2025 | Medical Devices & Rad Health | Clean | |
| 16 Aug 2022 – 23 Aug 2022 | Human Drugs | 483 | View 483 → |
| 5 Oct 2015 – 8 Oct 2015 | Human Drugs | 483 | View 483 → |
| 26 Aug 2014 – 5 Sep 2014 | Human Drugs | 483 | View 483 → |
| 5 Oct 2010 | Not recorded | Clean | |
| 7 May 2009 | Not recorded | Clean | |
| 21 Aug 2008 | Not recorded | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
15 Jan 2026
21 CFR 211.192
Written record of investigation incomplete
Cited by Milton J De Jesus Tavarez, Jeffrey T Prosterman
15 Jan 2026
21 CFR 211.22(d)
Procedures not in writing, fully followed
Cited by Milton J De Jesus Tavarez, Jeffrey T Prosterman
15 Jan 2026
21 CFR 211.67(b)
Written procedures not established/followed
Cited by Milton J De Jesus Tavarez, Jeffrey T Prosterman
15 Jan 2026
21 CFR 211.84(d)(2)
Component written specification
Cited by Milton J De Jesus Tavarez, Jeffrey T Prosterman
23 Aug 2022
21 CFR 211.113(a)
Procedures for non-sterile drug products
Cited by Charles D Brown, Shanna N Purdy
Investigators
FDA investigators tied to this site in the record.
Milton J De Jesus Tavarez1 insp.
Jeffrey T Prosterman1 insp.
Roy Baby1 insp.
Katherine M Thames1 insp.
Charles D Brown1 insp.
Shanna N Purdy1 insp.
Massoud Motamed1 insp.
Latorie S Jones1 insp.
Patty P Kaewussdangkul1 insp.
Adrian Rodriguez1 insp.
Johann M Fitch1 insp.
Karlton T Watson1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.56(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.113(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.166(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.180(e)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b)(5) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(b) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Goodier Cosmetics LLC's 5 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat